Canada-based venture capital firm Amplitude Venture Capital has closed its debut precision medicine fund at C$200m ($163m) with backers including life sciences real estate investment trust Alexandria Real Estate Equities.
Financial services firm Royal Bank of Canada and Alberta Enterprise (on behalf of the Province of Alberta) also contributed to the fund, Alexandria Real Estate Equities taking part through its VC arm, Alexandria Venture Investments.
Dion Madsen and Jean-François Pariseau founded Amplitude in late 2019 after working on the healthcare investing team at the state-owned BDC Capital, which also committed capital to the Amplitude fund.
Amplitude has so far invested in 10 companies, including Repare, Deep Genomics, Notch Therapeutics, Giiant Pharma and Radiant Biotherapeutics.
